Oberwil, Switzerland

Kaspar Zimmermann

USPTO Granted Patents = 3 


Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Oberwil BL, CH (2009)
  • Oberwil, CH (2005 - 2011)

Company Filing History:


Years Active: 2005-2011

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Innovations of Kaspar Zimmermann

Introduction

Kaspar Zimmermann is a notable inventor based in Oberwil, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic applications.

Latest Patents

Zimmermann holds three patents, with his latest innovations focusing on advanced pharmaceutical compounds. One of his notable patents involves fused pyridine derivatives that serve as vanilloid receptor antagonists for treating pain. This invention provides compounds of a specific formula that are useful as pharmaceuticals. Another significant patent includes benzo[1,2,5]oxadiazoles and benzo[1,2,5]thiadiazoles, which are useful as histopathological staining agents, imaging agents, and biomarkers. This invention relates to novel compounds that have various applications in diagnosis and treatment.

Career Highlights

Kaspar Zimmermann has built a successful career at Novartis AG, a leading global healthcare company. His work has contributed to advancements in medical science, particularly in pain management and diagnostic techniques.

Collaborations

Throughout his career, Zimmermann has collaborated with esteemed colleagues, including Yves Auberson and Samuel Hintermann. These collaborations have fostered innovation and have led to the development of groundbreaking pharmaceutical solutions.

Conclusion

Kaspar Zimmermann's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…